137 related articles for article (PubMed ID: 7882361)
1. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene.
Groden J; Joslyn G; Samowitz W; Jones D; Bhattacharyya N; Spirio L; Thliveris A; Robertson M; Egan S; Meuth M
Cancer Res; 1995 Apr; 55(7):1531-9. PubMed ID: 7882361
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
Green DW; Roh H; Pippin JA; Drebin JA
J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
[TBL] [Abstract][Full Text] [Related]
3. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
4. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
[TBL] [Abstract][Full Text] [Related]
5. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
Wakita K; Tetsu O; McCormick F
Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the adenomatous polyposis coli (Apc) and mutated in colorectal cancer (Mcc) genes in mouse lung neoplasia.
Oreffo VI; Robinson S; You M; Wu MC; Malkinson AM
Mol Carcinog; 1998 Jan; 21(1):37-49. PubMed ID: 9473770
[TBL] [Abstract][Full Text] [Related]
7. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene.
Li Y; White R
Cancer Res; 1996 Jun; 56(12):2872-6. PubMed ID: 8665528
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18.
Tanaka K; Oshimura M; Kikuchi R; Seki M; Hayashi T; Miyaki M
Nature; 1991 Jan; 349(6307):340-2. PubMed ID: 1670965
[TBL] [Abstract][Full Text] [Related]
9. [Development of a detection system (APC yeast color assay) of APC mutations by color change of yeast].
Furuuchi K
Hokkaido Igaku Zasshi; 2000 Nov; 75(6):385-97. PubMed ID: 11193931
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene.
Gerner EW; Ignatenko NA; Lance P; Hurley LH
Ann N Y Acad Sci; 2005 Nov; 1059():97-105. PubMed ID: 16382048
[TBL] [Abstract][Full Text] [Related]
11. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
[TBL] [Abstract][Full Text] [Related]
12. APC-dependent regulation of ornithine decarboxylase in human colon tumor cells.
Fultz KE; Gerner EW
Mol Carcinog; 2002 May; 34(1):10-8. PubMed ID: 12112318
[TBL] [Abstract][Full Text] [Related]
13. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
[TBL] [Abstract][Full Text] [Related]
15. Immunodetection of the presence or absence of full-length APC gene product in human colonic tissues.
Chop AM; Abraham CL; Adrian TE; Murphy R; Boman BM
Anticancer Res; 1995; 15(3):991-7. PubMed ID: 7645991
[TBL] [Abstract][Full Text] [Related]
16. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C
Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
18. Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin.
Chung CS; Jiang Y; Cheng D; Birt DF
Mol Carcinog; 2007 Sep; 46(9):773-82. PubMed ID: 17620292
[TBL] [Abstract][Full Text] [Related]
19. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
20. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
